Midgard Science

Altasciences

Overland Park, KS, United States altasciences.com From their website, Nov 2026

  • GLP

Work here? Claim this listing

About

Altasciences is a mid-size contract research organization and CDMO that supports preclinical and clinical drug development, bioanalysis, and manufacturing. It works with biopharmaceutical companies on early-phase programs from preclinical safety testing through Phase I and Phase II, with facilities in Canada and the U.S.

Services

  • Nonclinical Services

    Provides safety assessments and regulatory-ready nonclinical data for small and large molecules.

  • Lead Optimization Studies

    Runs non-GLP screening studies to help select promising drug candidates through PK, toxicology, and dose-response data.

    ADME, DMPK & toxicology

  • Dose Range-Finding Studies

    Conducts customized DRF and MTD studies to determine dose range, dose selection, and toxicity findings for IND-enabling work.

    ADME, DMPK & toxicology

  • Preclinical Pharmacology Studies

    Performs in vivo efficacy, safety, PK, and safety pharmacology studies in animal models.

    ADME, DMPK & toxicology

  • Pharmacokinetic and Pharmacodynamic Studies

    Characterizes exposure-response, ADME, bioavailability, bioequivalence, and toxicokinetics in preclinical models.

    ADME, DMPK & toxicology

  • Clinical Research Services

    Provides Phase I, Phase IIa, clinical pharmacology, and NDA-enabling clinical research services.

  • Proof-of-Concept Clinical Trials

    Designs and conducts early-phase proof-of-concept studies using biomarkers, endpoints, patient cohorts, and hybrid site models.

  • Bioavailability/Bioequivalence Studies

    Conducts BA/BE testing for small molecules and biologics, including absolute bioavailability and comparative studies.

15 more services
  • Human Abuse Potential Studies
  • Drug Product Formulation and Manufacturing Services
  • Method Development, Qualification, and Validation
  • Over-Encapsulation and Blinded Study Materials
  • Pharmaceutical Formulation Development
  • Wet Nanomilling and Vial Filling
  • Bioanalytical Services
  • Research Support Services
  • Nonclinical Research Services
  • Manufacturing and Analytical Services
  • Program Management
  • Medical Writing
  • Biostatistics
  • Clinical Monitoring
  • Data Management
Turnaround
  • Reduce drug development timelines by up to 40%
  • Move from first safety assessment to clinical proof-of-concept in as little as 18 months
What to send
  • Rabbit plasma
  • Participant panels
  • Healthy volunteers
  • Patients
  • Special populations

Capabilities

Assays and studies
  • Bioanalysis
  • Toxicology
  • LC-MS/MS
  • PK/PD
  • Oligonucleotides
  • Small molecules
17 more
  • In vivo
  • Antibodies
  • Stability studies
  • Safety pharmacology
  • Bioavailability
  • Bioequivalence
  • Clinical pathology
  • Hematology
  • Gross pathology
  • Histopathology
  • Analytical method validation
  • 8-Factor Analyses
  • Biomarker analysis
  • Ligand-binding
  • Immunotoxicology
  • Immunology
  • Immunogenicity
Scale and capacity
  • Four nonclinical facilities
  • 260 custom-designed animal rooms
  • 585,000 sq. ft. purpose-built space
  • Over 500 employees
  • Over 1,000 employees dedicated to clinical pharmacology research
  • Over 500 beds across the U.S. and Canada
11 more
  • 64,000 square-foot GMP manufacturing facility
  • Dosing of up to 72 participants in a single group
  • Global network of 300+ active partner sites
  • Three North American clinics
  • Over 700 nonclinical studies annually
  • Over 285 trials per year
  • 585,000 square feet of purpose-built space
  • 160 custom-designed animal rooms in Seattle
  • 80 custom-designed animal rooms in Columbia
  • Capacity to house ~3,680 NHPs, ~500 canines, ~12,000 rodents, and ~800 rabbits
  • Capacity to house ~200 NHPs, ~700 canines, ~800 swine, ~2,320 rodents, ~300 guinea pigs, and ~100 rabbits
Therapeutic areas
  • Cardiovascular diseases
  • Metabolic diseases
  • Infectious diseases
  • Gene therapy
  • Inflammation and autoimmune diseases
  • Musculoskeletal diseases
14 more
  • Neurology
  • Ocular diseases
  • Oncology
  • Immuno-oncology
  • Rare diseases
  • Respiratory diseases
  • CNS/neurology
  • Psychiatry
  • Substance abuse
  • Cardiology
  • Dermatology
  • Gastroenterology
  • Hematology
  • Immunology

Instruments and platforms

  • NETZSCH DeltaVita® 15-300 mill
  • Qualicaps Model 10
  • LC-MS/MS
  • Tandem mass spectrometry
  • Streptavidin magnetic beads

Modalities and species

Modalities
  • Small molecule
  • Antibody
  • ADC
  • Peptide
  • Oligonucleotide
  • Vaccine
  • Biosimilar
Species and models
  • Rodent
  • Non-rodent
  • NHPs
  • Canines
  • Rabbits
  • Miniature swine
9 more
  • Healthy volunteers
  • Patients
  • Special populations
  • Cell and gene therapy models
  • Genetically specific studies
  • Non-rodent species
  • Swine
  • Guinea pigs
  • European housing

Certifications

As the company states them, with the certificate or registry record where there is one.

  • AAALACSelf-reported

  • GMPSelf-reported

    As listed: cGMP

  • FDA registrationSelf-reported

    As listed: FDA-registered

  • GLPSelf-reported

Company

Type
CRDMO
Founded
1992
Team
Over 1,000 employees

Locations

Office
1200 Beaumont Avenue Montreal, QC H3P 3P1 Canada
Sites
  • Montréal, Canada
  • Laval, Canada
  • Everett, United States
  • Harleysville, United States
  • Cypress, United States
  • Scott Township, United States
5 more
  • Auxvasse, United States
  • Sacramento, United States
  • Kansas City, United States
  • Seattle, United States
  • Philadelphia, United States
Serves
Canada, United States, North America, global, U.S.

Public records

Parent company
ALTASCIENCES COMPANY INC. · CA GLEIF
CMS CLIA laboratory
17D2282640 · OVERLAND PARK source

Similar labs